| Medical and Health Sciences | Lifetime | 433 | US 235 | 99.98 |
| Medical and Health Sciences | 2021-2025 | 484 | US 167 | 99.90 |
| Psychiatry and Mental health | Lifetime | 15 | US 9 | 99.96 |
| Medical Physiology | Lifetime | 121 | US 70 | 99.81 |
| Clinical Neurology | Lifetime | 231 | US 97 | 99.10 |
| Neuroscience of Neurology | Lifetime | 162 | US 70 | 98.72 |
| Cognitive Neuroscience | Lifetime | 636 | US 322 | 98.46 |
| Cardiology and Cardiovascular Medicine | Lifetime | 980 | US 510 | 97.57 |
| Geriatrics and Gerontology | Lifetime | 271 | US 112 | 93.33 |
| Critical Care and Intensive Care Medicine | Lifetime | 548 | US 233 | 84.32 |
| Medical Physiology | 2021-2025 | 28 | US 15 | 99.63 |
| Psychiatry and Mental health | 2021-2025 | 23 | US 9 | 99.75 |
| Clinical Neurology | 2021-2025 | 117 | US 41 | 97.36 |
| Neuroscience of Neurology | 2021-2025 | 185 | US 60 | 89.19 |
| Radiology, Nuclear Medicine and Imaging | 2021-2025 | 646 | US 227 | 85.68 |
| Dementia and Cognitive Impairment Research | Lifetime | 6 | US 5 | 99.98 |
| Alzheimer's disease research and treatments | Lifetime | 20 | US 15 | 99.95 |
| Neurological Disease Mechanisms and Treatments | Lifetime | 23 | US 13 | 99.77 |
| Neurological and metabolic disorders | Lifetime | 16 | US 7 | 99.34 |
| Health Systems, Economic Evaluations, Quality of Life | Lifetime | 200 | US 102 | 99.35 |
| Cerebrovascular and genetic disorders | Lifetime | 14 | US 4 | 99.02 |
| Health, Environment, Cognitive Aging | Lifetime | 52 | US 23 | 98.94 |
| Frailty in Older Adults | Lifetime | 100 | US 46 | 98.92 |
| Cerebrovascular and Carotid Artery Diseases | Lifetime | 259 | US 117 | 99.22 |
| Advanced Neuroimaging Techniques and Applications | Lifetime | 223 | US 109 | 98.95 |
| Functional Brain Connectivity Studies | Lifetime | 364 | US 176 | 99.06 |
| Cardiovascular Health and Disease Prevention | Lifetime | 265 | US 119 | 98.61 |
| Parkinson's Disease Mechanisms and Treatments | Lifetime | 329 | US 118 | 98.87 |
| Blood Pressure and Hypertension Studies | Lifetime | 372 | US 165 | 98.86 |
| Cholinesterase and Neurodegenerative Diseases | Lifetime | 191 | US 80 | 98.38 |
| Nutritional Studies and Diet | Lifetime | 415 | US 169 | 98.56 |
| Ginkgo biloba and Cashew Applications | Lifetime | 104 | US 38 | 95.71 |
| Intensive Care Unit Cognitive Disorders | Lifetime | 824 | US 301 | 96.37 |
| Neuroprotection in Stroke and Neurodegeneration | Lifetime | 509 | US 155 | 95.25 |
| RNA regulation and disease | Lifetime | 803 | US 353 | 94.26 |
| Neurobiology of Language and Bilingualism | Lifetime | 588 | US 242 | 95.57 |
| Neurological diseases and metabolism | Lifetime | 551 | US 203 | 94.06 |
| Amyotrophic Lateral Sclerosis Research | Lifetime | 706 | US 230 | 93.31 |
| Amyloidosis: Diagnosis, Treatment, Outcomes | Lifetime | 911 | US 359 | 91.78 |
| Cognitive Functions and Memory | Lifetime | 279 | US 123 | 90.00 |
| Alcoholism and Thiamine Deficiency | Lifetime | 990 | US 423 | 83.38 |
| Dementia and Cognitive Impairment Research | 2021-2025 | 14 | US 7 | 99.89 |
| Alzheimer's disease research and treatments | 2021-2025 | 19 | US 12 | 99.79 |
| Health Systems, Economic Evaluations, Quality of Life | 2021-2025 | 122 | US 37 | 98.34 |
| Neurological Disease Mechanisms and Treatments | 2021-2025 | 114 | US 26 | 92.31 |
| Acute Ischemic Stroke Management | 2021-2025 | 652 | US 190 | 95.44 |
| Amyloidosis: Diagnosis, Treatment, Outcomes | 2021-2025 | 295 | US 94 | 89.63 |
| Advanced Neuroimaging Techniques and Applications | 2021-2025 | 975 | US 304 | 87.62 |
| Cerebrovascular and genetic disorders | 2021-2025 | 66 | US 10 | 84.65 |
| Intracerebral and Subarachnoid Hemorrhage Research | 2021-2025 | 674 | US 203 | 83.93 |
| Health, Environment, Cognitive Aging | 2021-2025 | 624 | US 277 | 82.46 |
| Neurological and metabolic disorders | 2021-2025 | 210 | US 43 | 71.29 |
| Cancer-related cognitive impairment studies | 2021-2025 | 697 | US 271 | 70.74 |
| Ginkgo biloba and Cashew Applications | 2021-2025 | 513 | US 42 | 50.07 |
